Fraunhofer USA

Fraunhofer USA


 

 

 

New Technologies, New Vaccines Conference Provides Opportunity to Share New Advancements in Combating Emerging Infectious Diseases, Including Ebola

More than 100 scientists, business leaders and regulatory agency representatives from around the world will convene at the Hotel DuPont in Wilmington, DE from March 22–25, 2015 for the 10th anniversary of the New Technologies, New Vaccines conference, to share advancements in the fight against deadly diseases and prevention of potential epidemics including chikungunya, dengue, Ebola, influenza and HIV.

The 3-day conference brings together leaders from business and industry, academia and government to discuss latest developments in therapeutic treatments and life-saving vaccines. The event is organized by Fraunhofer USA Center for Molecular Biotechnology (CMB), located at the Delaware Technology Park in Newark, Delaware, in cooperation with the International Association for Biological Standardization (IABS), headquartered in Geneva, Switzerland.

Initiated in 2006, the conference explores how new technologies are enhancing our ability to identify and design new vaccine candidates, develop safe and effective vaccine formulations using improved drug-enhancing agents and delivery mechanisms, and providing innovative manufacturing platforms to produce vaccines more safely, quickly and economically than traditional approaches.

Featured keynote speaker Kathryn Zoon, Ph.D., Director of the Division of Intramural Research (DIR) at National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), will present on the stages of vaccine development and current challenges. Dr. Zoon provides overall executive direction and scientific leadership for the division’s basic and clinical research activities, which cover a wide range of biomedical disciplines related to infectious diseases, immunology and allergy.

Additional topics planned over the 3-day conference include next generation products for prevention and treatment of auto-immune diseases such as cancer, HSV and HIV, advancements in protein expression and production methods and regulatory considerations for new technologies.

Conference registration and additional information is available online at www.ntnv.org.
 

News

President of the Fraunhofer-Ge...
Mon, 1/27/2014 - Prof. Reimund Neugebauer, President of the Fraunhofer-Gesellschaft, has been awarded an honorary doctoral degree by the Czech... more»
Fraunhofer ISE Awarded Prestig...
Mon, 1/27/2014 - Prof. Dr. Eicke R. Weber, director of the Fraunhofer Institute for Solar Energy Systems ISE, received the Zayed Future Energy... more»
Fraunhofer CCL and Michigan St...
Mon, 9/16/2013 - Fraunhofer USA is proud to announce that its research center, the Fraunhofer Center for Coatings and Laser Applications (CCL)... more»